To view our videos, you need to
enable JavaScript. Learn how.
install Adobe Flash 9 or above. Install now.

Then come back here and refresh the page.

The company says a packaging error could leave women with an inadequate dose of the hormone-based drug, raising a woman's risk of actually getting pregnant.

The recall affects lots of the Lo/Ovral-28 tablets and the generic Norgestrel and Ethinyl Estradiol tablets.

Pfizer found that some packages were found to have too many active tablets while some had too few.

For more information, visit www.fda.gov.